ORKA logo

ORKAOruka Therapeutics Inc.

$68.47
$4.44
(6.93%)
Today
Closed $68.47
$1.53
(2.23%)
After Hours
Updated: 07:35 PM EDT
Reported EarningsMay 13
Mkt Cap$3.86B
Vol1.19M
48

Neutral Sentiment

How do you feel about ORKA?

News
all
press releases
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Trade
The mean of analysts' price targets for Oruka Therapeutics, Inc. (ORKA) points to an 111.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
News Placeholder
More News
News Placeholder
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million...
Yahoo! Finance: News
News Placeholder
Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks
Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks $NTHI, $ORKA, $ABVX, $CGEM, $SYRE, $APGE
24-7 Market News
News Placeholder
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA...
Yahoo! Finance: News
News Placeholder
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon Technology
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon Technology Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop...
PR Newswire
News Placeholder
Best Biotech Stocks To Watch Today - May 3rd
Danaher, Moderna, Vertex Pharmaceuticals, Celcuity, and Oruka Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing, manufacturing, or commercializing biological or medical...
MarketBeat
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Trading Down 5.9% - Here's Why
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 5.9% - Here's Why...
MarketBeat
News Placeholder
Q2 EPS Estimate for Oruka Therapeutics Boosted by Analyst
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - Equities researchers at HC Wainwright raised their Q2 2026 earnings estimates for shares of Oruka Therapeutics in a note issued to investors on...
MarketBeat
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Up 22.4% in April
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totaling 5,537,531 shares, a growth...
MarketBeat
News Placeholder
Best Biotech Stocks To Watch Today - April 29th
Danaher, Oruka Therapeutics, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that apply biological research and technology to develop medicines, therapies, diagnostics, and...
MarketBeat
<
1
2
...
>